Leading the way to non-invasive neonatal therapies

ONY Biotech is a family-focused neonatology pharmaceutical company creating therapies that improve outcomes for premature babies and their families.

About us

For babies with respiratory distress syndrome, tomorrow is made possible by Infasurf® (calfactant).

Infasurf® (calfactant) helps prevent and treat respiratory distress syndrome in newborns, restoring surface activity in the lungs and quickly improving respiration.

Learn more

Latest News

Post-hoc Analysis of AERO-02 Trial Completed

July 26, 2023

Analysis results are in: nebulized calfactant reduced the need for instilled liquid surfactant by 50% in infants with clinical...

Over At ONY Biotech: Our Focus on Workplace Wellness

July 6, 2023

#OverAtONYBiotech, we understand that the strength of our company relies on the well-being and satisfaction of our employees. Workplace...

Big Moves at ONY Biotech

May 30, 2023

At ONY Biotech, we are guided by our 4 core values: persistence, passion, positivity, and professionalism. Every department exemplifies...

All News